Search

The Texas Health and Human Services Commission and the University of Texas Southwestern Medical Center are developing plans for a new state psychiatric hospital in the Dallas-Fort Worth area, with $44.7 million in state funding approved this Legislative session.

Scientists at UTSW have developed a technology that shuttles nanoparticles carrying gene editing and protein replacement tools to the specific tissues where they're needed.

Two new UT Southwestern studies published today report some surprising findings: Only half of practicing physicians are registered to vote, and the most common obstacle faced by resident physicians is the lack of time to vote.

Despite the high number of confirmed cases, the true prevalence of COVID-19 infections is believed to be underestimated due to insufficient testing capacity and a high percentage of asymptomatic people.

The widespread use of electronic patient portals to provide quick access to test results presents healthcare professionals with an important challenge: How should new cancer diagnoses be communicated?

Interpreting relatively inexpensive electrocardiograms (ECGs) with an artificial intelligence (AI) algorithm accurately screened patients for a key precursor of heart failure in Kenya, a study led by UT Southwestern Medical Center researchers shows.

A multidisciplinary team co-led by Amit Singal, M.D., Chief of Hepatology and Director of the Liver Tumor Program in the Division of Digestive and Liver Diseases at UT Southwestern Medical Center, has developed new treatment recommendations for liver cancer that incorporate the latest research and an expanding range of therapeutic options.

While Black and Hispanic families are enthusiastic about research participation, other provider and systems-focused factors may influence their involvement in pediatric oncology clinical trials, a new UT Southwestern Medical Center-led study has found.

A once-daily combination treatment for those with uncontrolled Type 2 diabetes amplifies the treatment’s effects – lowering both weight and the number of hypoglycemic events, and improving quality of life and glucose control ¬– and makes participants more likely to adhere to their medications.

Loss of an enzyme necessary for a process called lipoylation disrupts the way cancer cells copy their DNA, increasing their vulnerability to a class of anticancer drugs known as PARP inhibitors, a study led by UT Southwestern Medical Center researchers shows.